Completed NA INTERVENTIONAL 2-arm NCT01356615

Low Molecular Weight Heparin for Hemodialysis Anticoagulation

Low Molecular Weight Heparin (Enoxaparin Sodium) and Standard Unfractionated Heparin for Hemodialysis Anticoagulation

Sponsor: Tehran University of Medical Sciences

Conditions End Stage Renal Failure on Dialysis

Interventions low molecular weight heparin (enoxaparin sodium) standard unfractionated heparin

Updated 5 times since 2017 Last updated: May 18, 2011 Started: Mar 31, 2011 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates End Stage Renal Failure on Dialysis and is currently completed. Tehran University of Medical Sciences leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tehran University of Medical Sciences

Data source: Tehran University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.